Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Certain growth factors affect hair loss in women and could be targeted for treatment.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Minoxidil helps hair growth and reduces shedding in women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Hair restoration for East Asians should consider their unique characteristics like head shape, hair thickness, and hair density, and use modified procedures and treatments to minimize scarring and maintain hair density.

Thyroid function may influence hair loss after COVID-19.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

The serum is safe and effective for treating hair loss.

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Different hair loss patterns may be linked to varying male hormone levels.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

5% minoxidil foam used once daily is as effective as 2% minoxidil solution used twice daily for hair loss in women, but with fewer side effects like itching and dandruff.

Low levels of ferritin, TSH, and certain vitamins are linked to hair loss in women of different ages.

Most patients with hair loss sought treatment for cosmetic reasons, were unhappy about their appearance, and had a family history of the condition, suggesting it may be inherited.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.